Martin Kohan
Managing Toxicologist
Martin Kohan is BSc and MSc in Chemistry and Biochemistry from the National University of La Plata, Argentina. MSc in Pharmacology and PhD in Medical Sciences from the Hebrew University of Jerusalem, Israel. Over 20 years of experience in Pharmacology and Toxicology, including more than 14 years of industry experience in Toxicology conducting and managing over 1000 hazard/risk assessments, including calculation of exposure limits and/or determination of exposure bands for drug substances and isolated intermediates and quality deviations (impurities and extractables & leachables) for Teva (2010 – 2018), AstraZeneca (2018 – 2022), and SafeBridge (2022 – present). Diplomate of the American Board of Toxicology (DABT), European Registered Toxicologist (ERT), and Member of the UK Register of Toxicologists.
DAY 2: October 2nd, 2025
SESSION: Permitted Daily Exposures (PDEs) and Patient Safety
◆ What are PDEs?
◆ Calculation and implementation of PDEs.
◆ PDEs for compounds with limited data.
◆ Regulatory implications.
DAY 2: September 29th, 2023
SESSION: Exposure Limits and Bands for HPAPIs and the Importance of a Qualified Expert
◆ What are HPAPIs.
◆ Occupational Exposure Limits (OELs) and Bands (OEBs).
◆ Permitted Daily Exposures (PDEs).
◆ Profile of a Qualified Expert.
DAY 2: September 30th, 2021
SESSION: Occupational Exposure Bands (OEBs)
◆ What are OEBs?
◆ History of OEBs.
◆ Use and communication of OEBs.
◆ Case studies – OEBs for compounds with limited data.
